0001415889-22-007063.txt : 20220629
0001415889-22-007063.hdr.sgml : 20220629
20220629201258
ACCESSION NUMBER: 0001415889-22-007063
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220627
FILED AS OF DATE: 20220629
DATE AS OF CHANGE: 20220629
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Trachtenberg Eric
CENTRAL INDEX KEY: 0001646300
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38150
FILM NUMBER: 221056191
MAIL ADDRESS:
STREET 1: 1414 RALEIGH ROAD
STREET 2: SUITE 400
CITY: CHAPEL HILL
STATE: NC
ZIP: 27517
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kala Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001479419
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 270604595
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1167 MASSACHUSETTS AVENUE
CITY: ARLINGTON
STATE: MA
ZIP: 02476
BUSINESS PHONE: 781-996-5252
MAIL ADDRESS:
STREET 1: 1167 MASSACHUSETTS AVENUE
CITY: ARLINGTON
STATE: MA
ZIP: 02476
4
1
form4-06292022_050647.xml
X0306
4
2022-06-27
0001479419
Kala Pharmaceuticals, Inc.
KALA
0001646300
Trachtenberg Eric
C/O KALA PHARMACEUTICALS, INC.
1167 MASSACHUSETTS AVENUE
ARLINGTON
MA
02476
false
true
false
false
SEE REMARKS
Common Stock
2022-06-27
4
S
0
2613
0.37
D
111203
D
This sale was made pursuant to a 10b5-1 trading plan to cover tax withholding obligations in connection with the vesting and settlement of the reporting person's restricted stock units granted on June 25, 2020.
Includes 45,611 unvested RSUs.
General Counsel, Chief Compliance Officer and Secretary
/s/ Mary Reumuth, Attorney-in-Fact
2022-06-29